Dabur Sues Patanjali Over Toothpaste Trade Dress

New Delhi:  Dabur India on Wednesday moved the Delhi High Court alleging that Patanjali Ayurveda’s Dant Kanti Red infringed upon the trade dress of its Red toothpaste with pan flavour.

The court asked Patanjali Ayurved if it could modify the visual appearance of the product. The court posted the matter for further hearing on January 31.

The HC was hearing a suit filed by Dabur seeking a permanent injunction against Patanjali Ayurved, the parent company of Patanjali Foods, for the similarity in trade dress. Dabur said it did not have any grievance over the earlier packaging of Patanjali Ayurved in respect of similar products.

However, it is now becoming difficult to maintain a distinction between the two products due to the similarity in their trade dress, it said. Patanjali Ayurved launched its Dant Kanti Red toothpaste with pan flavour in December.

Related Posts

8 Women Develop Complications Post C-Section, 2 Critical

Close on the heels of maternal deaths and kidney-related complications reported in Kota and Bikaner following caesarean deliveries, a similar case has surfaced at Paota District Hospital in Jodhpur, where…

Kota District In-Charge Secretary Directs Implementation of Risk Management Framework in Hospitals; Emphasis on SOPs and Infection Control

Jaipur/Kota— In a significant move to strengthen patient safety and improve healthcare delivery in government hospitals, Kota district in-charge secretary Dr. Ravi Kumar Surpur has directed the immediate preparation and effective…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

8 Women Develop Complications Post C-Section, 2 Critical

8 Women Develop Complications Post C-Section, 2 Critical

Kota District In-Charge Secretary Directs Implementation of Risk Management Framework in Hospitals; Emphasis on SOPs and Infection Control

Kota District In-Charge Secretary Directs Implementation of Risk Management Framework in Hospitals; Emphasis on SOPs and Infection Control

Probe report into maternal deaths sparks Kota row

Probe report into maternal deaths sparks Kota row

Centre bans 16 Fixed-Dose Combination drugs over safety concerns

Centre bans 16 Fixed-Dose Combination drugs over safety concerns

Maha FDA seizes medicines worth Rs 9.09 lakh from Mumbai children’s hospital over alleged illegal sale

Maha FDA seizes medicines worth Rs 9.09 lakh from Mumbai children’s hospital over alleged illegal sale

CDSCO constitutes consultancy committee for advice on suo motu disclosure

CDSCO constitutes consultancy committee for advice on suo motu disclosure